Xiaolin Y Li from 9 Arbor Field Way, Lake Grove, NY 11755, age 68, Phone: 6315803028

Professor

view source

Location:

9 Arbor Field Way, Lake Grove, NY 11755

Industry:

Human Resources

Work:

Suny at Stony Brook
Professor
Stony Brook University
Professor

Education:

Columbia University In the City of New York 1982 - 1987

Skills:

Matlab
C++
Powerpoint
Physics
Computer Science
Teaching
Statistics
Algorithms
R
Programming
Data Analysis
Mathematica
Statistical Modeling
Research
Machine Learning
C

Xiaolin Li

view source

Xiaolin Li

view source

Xiaolin Avril Li

view source

Graphic Design At Web2Asia

view source

Position:

Graphic Design at Web2Asia

Location:

Shanghai City, China

Industry:

Fine Art

Work:

Web2Asia - Shanghai since Apr 2013
Graphic Design
SO-IL - Brooklyn Oct 2010 - Feb 2013
Communications Manager
Green Kids Media Jan 2012 - Apr 2012
Graphic Design
Emmis Communications Sep 2011 - Dec 2011
Graphic Design Intern
EDC | Center for Children and Technology Jun 2011 - Aug 2011
Graphic Design Intern

Education:

New York Institute of Technology-Old Westbury 2009 - 2011
BFA, Communication Arts

Skills:

Adobe Creative Suite
Microsoft Office
Mac OS X
Final Cut Pro
OS X
InDesign
Graphic Design

Languages:

English
Chinese

Awards:

2012 Dean's Teach with Today’s Technology Challenge 1st Place
The Dean's Teach with Today’s Technology Challenge is a challenge to School of Management (SoM) students to help them incorporate the newest and greatest Web 2.0 technologies into the curriculum. Our proposal integrated Web2.0 applications such as Twitter, Slideshare, YouTube, Facebook into a web interface at Wix.com to deliver knowledge content for the MGMT201 course. Interactive management games were also integrated into the content pages. The course content is portable to both Android and iOS based smart phones and also to tablets such as the iPad.

Xiaolin Li

view source

Xiaolin Li

view source

Associate Professor At Xiamen University

view source

Position:

Associate Professor at Xiamen University

Location:

Xiamen, Fujian, China

Industry:

Chemicals

Work:

Xiamen University - Xiamen, Fujian, China since Jan 2012
Associate Professor
ISTC University of Illinois at Urbana-Champaign Apr 2010 - Dec 2011
Research Fellow
The Connecticut Agricultural Experiment Station Jun 2009 - Apr 2010
Post-doc

Education:

State University of New York at Stony Brook 2003 - 2009
Ph.D., Oceanography, Chemical and Physical Xiamen University 2000 - 2003
M.S., Marine Chemistry Xiamen University 1996 - 2000
B.S., Marine Chemistry

Us Patents

Compounds And Compositions As C-Kit Kinase Inhibitors
view source
US Patent:

20130059846, Mar 7, 2013
Filed:

Aug 27, 2012
Appl. No.:

13/595575
Inventors:

Vince YEH - San Diego CA, US
Xiaolin LI - Emeryville CA, US
Xiaodong LIU - San Diego CA, US
Jon LOREN - San Diego CA, US
Valentina MOLTENI - San Diego CA, US
Juliet NABAKKA - San Diego CA, US
Bao NGUYEN - San Diego CA, US
Hank Michael James PETRASSI - Cardiff CA, US
Assignee:

IRM LLC - Hamilton
International Classification:

A61K 31/437
A61K 31/496
A61K 31/5377
A61P 19/04
A61P 11/00
A61P 1/00
A61P 37/06
A61P 3/00
A61P 21/00
A61P 17/00
A61P 9/12
A61P 11/06
A61P 37/08
A61P 9/00
A61P 3/10
C07D 471/04
US Classification:

5142332, 546121, 514300, 544362, 51425304, 544127, 546 15
Abstract:

The invention provides compounds and pharmaceutical compositions thereof, which are useful as protein kinase inhibitors, as well as methods for using such compounds to treat, ameliorate or prevent a condition associated with abnormal or deregulated kinase activity. In some embodiments, the invention provides methods for using such compounds to treat, ameliorate or prevent diseases or disorders that involve abnormal activation of c-kit or c-kit and PDGFR (PDGFRα, PDGFRβ) kinases.

Supramolecular Functionalization Of Graphitic Nanoparticles For Drug Delivery
view source
US Patent:

20140017322, Jan 16, 2014
Filed:

Sep 16, 2013
Appl. No.:

14/028353
Inventors:

Zhuang Liu - Stanford CA, US
Xiaolin Li - Menlo Park CA, US
Xiaoming Sun - Palo Alto CA, US
Assignee:

The Board of Trustees of the Leland Stanford Junior University - Palo Alto CA
International Classification:

A61K 47/48
A61K 31/337
A61K 31/704
A61K 39/395
A61K 38/16
US Classification:

424490, 424400, 4241781, 514 211, 514 34, 514449, 514785, 514788, 530300, 5303917, 536 64, 549510, 428402
Abstract:

Disclosed are nanoparticles, such as carbon nanotubes or other graphitic sheet materials having extended aromatic surfaces, which are used to deliver active agents such as drugs, labels or dyes (termed for convenience a “drug”) to the interior of cells. The nanoparticles are functionalized by a hydrophilic polymer or adsorption of an amphiphilic molecule to render them stable in suspension. The drug is therefore capable of release in the cell exterior. The drug is more rapidly released at lower pH, as found e.g., in tumor cells. The drug may also be linked to a branched chain hydrophilic polymer, so that each polymer molecule carries more than one drug bound by a cleavable linker.

Antiviral Pyridopyrazinedione Compounds
view source
US Patent:

20230052629, Feb 16, 2023
Filed:

Jun 21, 2021
Appl. No.:

17/352734
Inventors:

- Basel, CH
Xiaolin Li - Alameda CA, US
Peichao Lu - Pleasant Hill CA, US
Naomi Samadara Rajapaksa - Fremont CA, US
David Charles Tully - Danville CA, US
Xiaojing Michael Wang - Livermore CA, US
Qian Zhao - Louisville CO, US
International Classification:

C07D 471/04
A61P 31/22
Abstract:

The invention provides compounds of Formula (I)as described herein, along with pharmaceutically acceptable salts, pharmaceutical compositions containing such compounds, and methods to use these compounds, salts and compositions for treating viral infections, particularly infections caused by herpesviruses.

Antiviral Pyridopyrazinedione Compounds
view source
US Patent:

20200079772, Mar 12, 2020
Filed:

Sep 12, 2019
Appl. No.:

16/569107
Inventors:

- Basel, CH
Xiaolin Li - Alameda CA, US
Peichao Lu - Pleasant Hill CA, US
Naomi Samadara Rajapaksa - Fremont CA, US
David Charles Tully - Danville CA, US
Xiaojing Michael Wang - Livermore CA, US
Qian Zhao - Louisville CO, US
International Classification:

C07D 471/04
A61P 31/22
Abstract:

The invention provides compounds of Formula (I)as described herein, along with pharmaceutically acceptable salts, pharmaceutical compositions containing such compounds, and methods to use these compounds, salts and compositions for treating viral infections, particularly infections caused by herpesviruses.

Quinolone Derivatives As Antibacterials
view source
US Patent:

20170217897, Aug 3, 2017
Filed:

Aug 3, 2015
Appl. No.:

15/500870
Inventors:

Zhigan JIANG - Shanghai, CN
Jianhua XIA - Shanghai, CN
Haiying HE - Shanghai, CN
- Basel, CH
Xiaolin LI - Alameda CA, US
Peichao LU - Pleasant Hill CA, US
Wosenu MERGO - Oakland CA, US
Daniel MUTNICK - Concord CA, US
Folkert RECK - Walnut Creek CA, US
Alexey RIVKIN - Emeryville CA, US
Colin Keith SKEPPER - Alameda CA, US
Xiaojing Michael WANG - Livermore CA, US
Yongjin XU - Castro Valley CA, US
International Classification:

C07D 215/38
A61K 31/4709
A61K 31/496
C07D 401/14
C07D 413/14
C07D 419/14
C07D 405/14
C07D 471/04
C07D 498/10
A61K 31/5377
A61K 31/5386
C07D 487/10
C07D 471/10
A61K 45/06
C07D 401/04
Abstract:

This invention is in the field of medicinal chemistry and relates to compounds, and pharmaceutical compositions thereof, that inhibit bacterial gyrase. The compounds are useful as inhibitors of bacterial gyrase activity and bacterial infections, and have the structure of Formula (I)as further described herein. The invention further provides pharmaceutical compositions comprising a compound of Formula (I) and methods of using the compounds and compositions to treat bacterial infections.

Cyclic Peptides And Use As Medicines
view source
US Patent:

20150306172, Oct 29, 2015
Filed:

May 20, 2015
Appl. No.:

14/717872
Inventors:

Jiping Fu - Danville CA, US
Subramanian Karur - Dublin CA, US
Xiaolin Li - Alameda CA, US
Peichao Lu - Pleasant Hill CA, US
Wosenu Mergo - Oakland CA, US
Alexey Rivkin - Emeryville CA, US
Zachary Kevin Sweeney - Redwood City CA, US
Meiliana Tjandra - Dublin CA, US
Andrew Weiss - San Francisco CA, US
Aregahegn Yifru - Pleasant Hill CA, US
Assignee:

NOVARTIS AG - Basel
International Classification:

A61K 38/13
A61K 45/06
C07K 7/64
Abstract:

The present invention provides a compound of formula I;or a pharmaceutically acceptable salt thereof, wherein R, R, R, R, R, and A-B are as defined herein, which are non-immunosuppressive, cyclophilin-binding, mPTP blockers and are therefore useful for the prevention or treatment of diseases or disorders such as HCV infection, stroke, multiple sclerosis, HBV infection, HPV infection, asthma, cancer, muscular dystrophy, sepsis, ischemia/reperfusion injury, and heart failure.

Compounds And Compositions As C-Kit Kinase Inhibitors
view source
US Patent:

20150051206, Feb 19, 2015
Filed:

Aug 29, 2012
Appl. No.:

14/241884
Inventors:

Jon Loren - San Diego CA, US
Xiaolin Li - Emeryville CA, US
Xiaodong Liu - San Diego CA, US
Valentina Molteni - San Diego CA, US
Juliet Nabakka - San Diego CA, US
Bao Nguyen - San Diego CA, US
Hank Michael James Petrassi - Cardiff CA, US
Vince Yeh - San Diego CA, US
Paul Vincent Rucker - Carlsbad CA, US
Assignee:

IRM LLC - Hamilton
International Classification:

C07D 471/04
US Classification:

5142332, 546121, 514300, 544127, 544362, 51425304, 544405, 51425505, 544333, 514256, 544238, 51425204
Abstract:

The invention provides compounds and pharmaceutical compositions thereof, which are useful as protein kinase inhibitors, as well as methods for using such compounds to treat, ameliorate or prevent a condition associated with abnormal or deregulated kinase activity. In some embodiments, the invention provides methods for using such compounds to treat, ameliorate or prevent diseases or disorders that involve abnormal activation of c-kit or c-kit and PDGFR (PDGFRα, PDGFRβ) kinases.

Cyclic Peptides And Use As Medicines
view source
US Patent:

20140134132, May 15, 2014
Filed:

Sep 26, 2013
Appl. No.:

14/037644
Inventors:

Jiping Fu - Danville CA, US
Subramanian Karur - Dublin CA, US
Xiaolin Li - Alameda CA, US
Peichao Lu - Pleasant Hill CA, US
Wosenu Mergo - Oakland CA, US
Alexey Rivkin - Emeryville CA, US
Zachary Kevin Sweeney - Redwood City CA, US
Meiliana Tjandra - Dublin CA, US
Andrew Weiss - San Francisco CA, US
Aregahegn Yifru - Pleasant Hill CA, US
Assignee:

NOVARTIS AG - Basel
International Classification:

A61K 38/12
A61K 45/06
C07K 7/64
US Classification:

424 854, 530321, 514 43, 514 179, 514 37, 514 17, 514 199, 514 164, 514 211
Abstract:

The present invention provides a compound of formula I;or a pharmaceutically acceptable salt thereof, wherein the variables R, R, R, R, R, and A-B are defined herein, which are non-immunosuppresive, cyclophilin-binding, mPTP blockers and are therefore useful for the prevention or treatment of diseases or disorders such as HCV infection, stroke, multiple sclerosis, HBV infection, HPV infection, asthma, cancer, muscular dystrophy, sepsis, ischemia/reperfusion injury, and heart failure.